Last reviewed · How we verify
Moderate NMB using rocuronium
At a glance
| Generic name | Moderate NMB using rocuronium |
|---|---|
| Sponsor | Asan Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients (NA)
- Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries (NA)
- Low Pressure Pneumoperitoneum and Postoperative Ileus (NA)
- Deep Neuromuscular Block on Postoperative Delirium in Lumbar Surgery (NA)
- The Effect of Deep Neuromuscular Block and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Shoulder Surgery Using a Deltopectoral Approach (PHASE4)
- Moderate vs Deep Neuromuscular Block in Lower Pressure Pneumoperitoneum (NA)
- Comparison Of Deep Versus Moderate Neuromuscular Blockade on Intra-Operative Blood Loss During Spinal Surgery (EARLY_PHASE1)
- RCT Deep vs Moderat NMB on Surgical Conditions During THP (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Moderate NMB using rocuronium CI brief — competitive landscape report
- Moderate NMB using rocuronium updates RSS · CI watch RSS
- Asan Medical Center portfolio CI